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Abstract—In this review paper, some applications of the mixed
effect modeling in medial image processing and longitudinal
analysis is studied. For this purpose, a general structure is
extracted from some of the researches in the literature. This
structure includes a number of essential elements, each of
which having a few design choices, namely 1) tracked features,
2) model’s mathematical expression and random effects and
finally 3) response prediction. Two research study examples in
Alzheimer’s disease and prostate tomography are also briefly
introduced to further discuss the above design choices.
Index Terms—Mixed effect model, Medical image processing,
Longitudinal studies.
I. INTRODUCTION
W ITH the increasing prevalence of the signal process-ing applications in the medical science, the need for
sophisticated automated processing tools is more perceived.
One group of these applications deals with different imaging
systems (e.g. MRI, CT, X-ray etc.), where one can derive
useful information by studying big and diverse datasets of
images taken from different patients in different stages of a
disease. However, this diversity and plurality of data is helpful
only if a proper and accurate automated tool is designed to
process them.
Longitudinal study and disease tracking using medical
imaging is one of the most important and effective processes
during the medical treatment. Generally speaking, this pro-
cedure usually requires images regularly taken from patients’
organ(s) involving in disease evolution. The information in
these images hopefully guides to make better estimations
regarding the future state of the organs and observe the impact
of different drugs in different situations. For instance, one
might be interested to discover the impact of a specific dosage
of an anti-cancer drug on the size of the tumor through the
time. Therefore, the question is how to benefit from the latent
information in the temporally diverse set of medical images
taken from different patients.
Statistical modeling and prediction is a practical and ef-
fective solution to address the above problem. The main idea
is to exploit the repetitive behavior of the organ/tumors in
response to a new condition (e.g. drug injection, aging etc.)
and derive an accurate pattern. Like other similar machine
learning and statistical modeling problems, this task requires a
diverse image dataset with a reasonable size taken in different
conditions. However, it has always been costly and more im-
portantly dangerous to take excessive images from individual
patients to specifically model their disease. The most feasible
solution to this problem is to combine image datasets from
different patients with the same disease condition and produce
a rather general model. However, this simplification would
compromise accuracy of the model due to the patient-specific
behaviors of the treatments.
In this paper, we review the use of a statistical technique
called mixed-effect modeling, to take into account patient-
specific behaviors. As will be discussed, this technique helps
the modeling process improve the accuracy in the longitudinal
organ/tumor tracking. The rest of this paper is organized as
follows. In section II, the general framework of a prediction
system is described in detail. In section III, two example
research projects with different prediction systems for tracking
two different medical phenomenons have been studied. Finally,
section IV concludes the paper with some discussions about
the topic.
II. GENERAL FRAMEWORK OF A PREDICTION SYSTEM
USING MIXED EFFECT MODEL
In this section, we first explain principles of the mixed-
effect modeling and its necessity in the modeling of a complex
medical treatment process. Then, the main elements of a
prediction system based on the mixed-effect modeling and
their different choices are discussed.
A. Principles of the mixed-effect modeling
Basically, mixed-effect modeling or mixed modeling is a
flexible statistical technique to exploit regularity in the pattern
of a phenomenon which consists of both fixed and random
effects. Herein, the term effect refers to a system parameter
that somehow impact the prediction value. This impact can be
either non-random (i.e. fixed effects) or random (i.e. random
effect) [1] [cite mixed effect.pdf]. In matrix notation, a mixed-
effect model can be represented as eq. 1:
y = f(β) + g(γ) + ε, (1)
where f(β) and g(γ) are fixed and random effects of the model
and ε is the prediction error.
B. Key elements of a mixed effect modeling system
By taking a look at the longitudinal studies with medical
image processing, one can spot a few common essential
elements. Here we briefly describe these elements [2].
21) Tracked features: Depending on the disease under study,
the tracked feature can be different. In the problems dealing
with different types of cancers, the objective is to observe
and model the growth in the size of tumor. “Sum of longest
diameters” and “Mean tumor diameter” are two size-related
features that can fairly represent the status of the tumor and
also can be helpful in tracking it. According to the Response
Evaluation Criteria in Solid Tumors (RECIST) [3], these
features are allowed to be measured and tracked for on a
limited set of organs associated with lesions.
However in other problems than the tomography, one might
aim at monitoring more complicated features of the organ
e.g. shape, displacement etc. For this purpose, some of the
researches directly deal with pixels/voxels of the medical
images taken from patients. In the simplest scenario, one might
use each pixel/voxel of the image as one independent feature
to track. More advanced approaches apply so-called feature
reduction techniques such as Principle Component Analysis
(PCA) to shrink the feature space [4].
There are also some other features that are used for tracking
an organ’s status through the time. For instance, in a research
for studying the tumor growth rate, the Prostate-Specific
Antigen (PSA) was tracked in order to monitor the prostate
cancer status [5].
2) Mixed-effect modelisation: In the design of a mixed-
effect model, there are different choices to make. One impor-
tant choice is the mathematical expression used in modelisa-
tion. There are mainly two types of mixed-effect models in
the literature:
• Algebraic equations with the general form of:
y(t) = y0 + e
−d.t + g.t. (2)
• Differential equation with the general form of:
dy
dt
= y0 + e
−d.t + g.t. (3)
In both equations, y is the tracked feature, t is time and d
is the model parameter. In this equation, the term exponential
term of e−d.t is the random effect and the the term g.t is the
fixed effect in the model.
Once the mathematical expression is decided, one should
decide about the number and the nature of random effects of
the model. For example, here is a list of some popular random
effects used in the literature of anti-cancer drug treatment:
• Drug-indudec decay of tumor
• Net growth of tumor size
• Tumor size nadir (the transition between decay and
growth)
• Drug concentration
3) Response prediction: As soon as the mixed effect model
is trained with the training data, it can be used as a tool
for prediction. This prediction generally includes estimation
of future state of the tracked feature. The Expectation Maxi-
mization (EM) is one of the popular methods for addressing
the response prediction problem.
III. EXAMPLE RESEARCHES USING THE MIXED EFFECT
MODEL BASED PREDICTION FRAMEWORK
After introducing the mixed effect modeling and its adoption
in the longitudinal studies, here we briefly introduce two
example researches in this domain.
A. A study on Alzheimer’s disease by Opsina et al. [6]
In this research, the authors have studied the temporal evo-
lution the “gray matter”, which is a very important indicator
of progress in Alzheimer’s disease. Gray matter is the darker
tissue of the brain and spinal cord, consisting mainly of nerve
cell bodies and branching dendrites [7]. The volume of this
tissue is usually measured and tracked during treatment of
Alzheimer’s disease.
The main purpose in this study is to model the impact
of aging on the cortical gray matter quantification for two
groups of subjects: healthy elderly (HE) and Alzheimer’s
disease (AD) patients. For this purpose, the high-level feature
of gray matter volume is represented by low-level voxel-based
morphology from MRI, PET and other biological markers.
These voxels are then analyzed both in the temporal and spatial
domains to build a mixed effect model.
A non-parametric framework is used to model both groups
of HD and AD subjects. For each normalized voxel x from
each subject i, where i = {1, ..., n}, this framework is
expressed as:
fi(x, age) = m(x, age)+g(x, age).Φi+ei(x, age)+εi(x, age),
(4)
wherem, g and ei are unknown functions and εi is a random
error. Moreover, the flag Φ is one if the i-th subject is an
AD and is zero, otherwise. In the above equation, The term
m(x, age) + g(x, age) represents the expected density of the
gray matter in an AD subject. Therefore, it can be understood
that the role of flag Φ is to consider the gray matter emission
in the AD group of subjects, due to their disease. Furthermore,
ei(x, age) is deviation of the i-th subject from the voxel mean
value corresponding to its group.
The analysis of this paper confirms that an age-dependent
gray matter volume decrease usually happens both in HE
and AD subjects. It also confirms that this decrease is more
significant in the AD subjects than the HE subjects. Among
the AD subjects, it was concluded that the rate of reduction
in the gray matter become steeper with aging.
B. A study on Prostate cancer by Rios et al. [4]
In this research, the side-effects of radiotherapy in the
prostate cancer treatment is analyzed using mixed effect mod-
eling. The particular effect that has been studied in this paper
is the bladder movement. The ultimate goal is to propose
a mixed effect model, in order to enable an accurate and
efficient bladder motion estimation under exposure of the
cancer treatment drug. In contrast to the previous research
example, here all the subjects are patients and the proposed
approach tries to effectively model inter- and intra-patient
behaviors of the bladder. Hence, the inter-patient features and
3the intra-patient features are considered as the fixed effects
and random effects of the model, respectively.
From a high-level point of view and considering the frame-
work introduced in section II, the proposed model of this paper
can be summarized in the following 5 steps.
1) Imaging : The very first step of the proposed process
is the computed tomography imaging. In this step, raw data
is taken from a diverse set of patient s through the treatment
period. As this data naturally contains enormous outlier and
noise, the next steps are performed to refine it and extract the
most useful information from it.
2) Spatial normalization of the input images : In this step,
raw images taken in step one are processed to clip and extract
the region of interest (i.e. the bladder). For this purpose, the
three-dimensional space of voxels are processed and shrank
to a reduced space of 135 × 215 × 55 voxels containing the
bladder voxels.
3) Surface representation: Each bladder image extracted
from step 2 is a solid volume. Therefore, all voxels in the
three-dimensional space which occur inside that volume can
be ignored during the process. This is due to the fact that
each 3D volume can be perfectly represented only by using its
outer surface. To this end, a mehtod called Spherical Harmonic
(SPHARM) was adopted. SPHARM takes each image from the
previous step in the 135× 215× 55 space and projects it to a
further reduced space of 272 voxels.
4) Feature reduction using PCA: Considering the relatively
small size of the dataset and also the fact that increasing it is
extremely costly and harmful to the patients, one might further
reduce the feature space. This step is necessary, since it is a
proven rule in the machine learning that, when the size number
of samples are limited, the size of feature space should be
small enough to be trainable.
The Principle Component Analysis (PCA) is a well-known
method for efficient feature reduction. In this method, a
statistical analysis is performed on the data and the target
model, in order to detect uncorrelated part of the dataset.
The expected output of this process is a reduced space which
still contains a reasonably informative part of the data. In
the research conducted in this paper, the PCA step reduces
the feature space from 272 features to only 40 features. This
set of 40 values, is considered as the final feature vector of
each sample ans used in the rest of the mixed effect modeling
process.
5) Mixed effect modeling : According to the four previous
steps, each image taken from patients is represented by a set of
40 features and the goal is to produce 40 independent mixed
effect models associated to each feature. Let assume that there
are n patients in the dataset and number of ji (i = 1, ..., n)
images have been taken from each patient. Also, let z be the
measure of motion/deformation that is aimed to be modeled
(i.e. represented by the feature vectors). Therefore, it can be
said that zijk where i = 1, .., n, j = 1, ..., ji and k = 1, ..., 40
indicates the k-th feature of the i-th patient, taken at the j-th
period of his/her treatment. The mixed effect modeling of this
paper can be described as:
zijk = µk + bik + εijk. (5)
TABLE I
MIXED EFFECT MODEL IN THE MEDICAL IMAGING APPLICATIONS:
SUMMARY OF DIFFERENT ELEMENTS CHOICES.
Element Choices
Mathematical
expression
Algebraic equation
Differential equation
Tracked
features
Size-based features, such as the
“longest dumor diameter”
or the “mean tumor diameter”.
Voxel/Pixel-based features
following and optional
feature reduction step.
Other features line PSA.
Random
effects
Drug-induced decay in tumor.
Net growth of tumor size.
Nadir tumor size
Drug concentration
The µk term in the above equation represents the average
of the k-th features among all patients in all of their images.
The term bik is a random variable representing deviation
of the i-th patient from its mean µk and finally, εijk is a
random variable representing deviation of the i-th variable
from its personal mean. The these random variables follow
the Gaussian distribution functions:
bik ∼ N(0, σ
2
bk), (6)
and:
εijk ∼ N(0, σ
2
k). (7)
IV. CONCLUSION
In this paper, the use of mixed effect modeling in some
of the medical image processing application was reviewed.
To do this, first general philosophy behind the mixed effect
modeling and its necessity in such applications is explained.
Then the general principles and common elements of the
different models in the literature was described. For this
purpose, three different design elements in the process of
mixed effect modeling were detected. These elements and their
possible choices are summarized in Table I.
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